Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet

The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.

Related Posts

Leave a Reply

Recent Articles

Ethereum 2035: How the next 10 years might look
July 31, 2025
Bitcoin makes ‘big move’ after Fed rate decision, Coinbase Premium turns red
July 31, 2025
Cboe, NYSE Arca move to streamline crypto ETF listings with SEC rule change request
July 31, 2025

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Post Category